Literature DB >> 3742708

Effects of sodium cyanate in mice bearing B16 melanoma.

M A Lea, A Luke, O Velazquez, L Carpenter, C F Martinson, H Z Hill, G J Hill.   

Abstract

Sodium cyanate injected IP at a dose level of 200 or 250 mg/kg caused a 90% or greater inhibition of the incorporation of [3H]thymidine into DNA of B16 melanoma transplanted SC in mice. Despite the inhibitory effect of sodium cyanate on precursor incorporation into DNA, no significant effect on host survival was observed when sodium cyanate was administered as a single agent in the diet, in drinking water, or by IP injection to mice that had received IP transplants of B16 melanoma. The action of melphalan and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in prolonging the survival time of melanoma-bearing mice was not enhanced by combined treatment with sodium cyanate. However, combined injections of sodium cyanate and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) increased the survival of tumor-bearing mice significantly more than injections of BCNU alone at a lower dose than the maximum tolerated one. These data and other studies suggest that B16 melanoma may be less responsive to the action of sodium cyanate than are murine leukemic cells or rat hepatomas.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3742708     DOI: 10.1007/bf00256690

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  15 in total

1.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

Authors:  K BURTON
Journal:  Biochem J       Date:  1956-02       Impact factor: 3.857

2.  Actions of cyanate.

Authors:  K M Birch; F Schütz
Journal:  Br J Pharmacol Chemother       Date:  1946-09

3.  Some new aspects of mitotic poisoning.

Authors:  P DUSTIN
Journal:  Nature       Date:  1947-06-14       Impact factor: 49.962

4.  Sodium cyanate: chemical properties relevant to sickle cell disease therapy.

Authors:  R F Labbe
Journal:  J Pharm Sci       Date:  1973-10       Impact factor: 3.534

5.  Carcinogenic nitrosamides and cell cultures.

Authors:  P Knox
Journal:  Nature       Date:  1976-02-26       Impact factor: 49.962

6.  Phase-I clinical trial of sodium cyanate in patients with advanced colorectal carcinoma.

Authors:  L Herrera-Ornelas; N J Petrelli; S Madajewicz; A Mittelman; V G Allfrey
Journal:  Oncology       Date:  1985       Impact factor: 2.935

7.  Effects of carbamoylation on cell survival and DNA repair in normal human embryo cells (IMR-90) treated with various 1-(2-chloroethyl)-1-nitrosoureas.

Authors:  E Sariban; L C Erickson; K W Kohn
Journal:  Cancer Res       Date:  1984-04       Impact factor: 12.701

8.  Effects of cyanate, thiocyanate, and amygdalin on metabolite uptake in normal and neoplastic tissues of the rat.

Authors:  M A Lea; M R Koch
Journal:  J Natl Cancer Inst       Date:  1979-11       Impact factor: 13.506

9.  Activation of sodium cyanate for selective inhibition of protein synthesis in cultured tumor cells.

Authors:  L C Boffa; S Kozak; V G Allfrey
Journal:  Cancer Res       Date:  1981-01       Impact factor: 12.701

10.  Effects of cyanate on the distribution of isotope-labeled H2O and extracellular markers in rat liver and tumors.

Authors:  M A Lea; J Parsons
Journal:  Cancer Res       Date:  1981-12       Impact factor: 12.701

View more
  1 in total

1.  Combined effect of pH and sodium cyanate on the inhibition of tumor cell proliferation and metabolism by BCNU and hyperthermia.

Authors:  J J Hu; K A Zirvi; M A Lea
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.